Reckitt Benckiser Pl (RBGLY) 18.2100 $RBGLY
Global Gastrointestinal OTC Drugs Market 2015-2019
M2 - Thu Apr 30, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6bnnqx/global) has announced the addition of the "Global Gastrointestinal OTC Drugs Market 2015-2019" report to their offering. OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Strategic alliances among vendors that lead to market consolidation are expected to have a positive impact on market growth during the forecast period. Collaborations among the leading vendors help them to obtain an edge over smaller companies. According to the report, the increased patient population has a positive impact on market growth. The growing incidence of gastrointestinal disorders and a rise in the geriatric population has led to an increase in the overall patient population. Patients undergo self-diagnosis and self-medication leading to increased consumption of OTC drugs. Further, the report states that increased expenditure on advertisements of the drugs hinders the growth of the market. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as: - GERD/Heartburn - Constipation - Diarrhea - Nausea due to motion sickness - Flatulence Key vendors - Bayer - GlaxoSmithKline - Johnson & Johnson - Perrigo - Pfizer - Procter & Gamble Other prominent vendors - Abbott - Boehringer Ingelheim - C.B. Fleet - Nestle - Omega - Purdue Pharma - Reckitt Benckiser - Sanofi - Teva Pharmaceutical For more information visit http://www.researchandmarkets.com/research/6bnnqx/global
JNJ: 103.42 (+1.12), PRGO: 198.37 (+3.87), PG: 80.74 (-0.31), GSK: 44.66 (-0.11)
New Report Highlights Lack of Chemical Screening Criteria in Cleaning Industry
GlobeNewswire - Tue Apr 28, 10:37AM CDT
A new report released by national women's health non-profit, Women's Voices for the Earth (WVE), finds that the cleaning product industry is falling short in meeting consumer demands for safer products.
The Weekender
Aviate - at Seeking Alpha - Sun Apr 26, 12:25AM CDT
Reading the tea leaves Earnings season brings with it a deluge of corporate numbers and whilst it can be easy to get caught up in the micro, we have spent much time this week looking through the numbers and focusing on what corporates are telling...
VGK: 58.07 (-0.35), PCAR: 65.77 (-0.68), TI: 12.31 (-0.22), ILMN: 200.76 (+1.69), SPY: 213.10 (+0.66), SAP: 75.63 (-1.20), DIA: 182.68 (+0.20), HBI: 31.83 (+0.52), RIO: 45.64 (-0.49), ALU: 3.77 (+0.01), ALV: 126.18 (+1.39), MAN: 87.08 (+0.89), WPPGY: 122.67 (+0.03), EU: 20.54 (-0.08), VOD: 36.51 (-0.53), TUP: 67.55 (+0.49), ABB: 22.15 (-0.06), NVO: 56.92 (+0.17), QQQ: 110.06 (+0.48), ARMH: 52.19 (+0.39), CRH: 28.57 (-0.19)
Solid Q1 for Reckitt Benckiser
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:07AM CDT
European Stocks Take Positive View of Greece Debt Talks; HSBC Rises
at The Street - Fri Apr 24, 5:13AM CDT
European stocks are rising as European ministers meet with Greece over bailout funds and as HSBC threatens to leave the U.K.
GE: 27.31 (+0.04), HSBC: 48.45 (-0.36)
Global Gastrointestinal OTC Drugs Market 2015-2019
M2 - Thu Apr 30, 10:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6bnnqx/global) has announced the addition of the "Global Gastrointestinal OTC Drugs Market 2015-2019" report to their offering. OTC drugs are medications that do not require a prescription. In contrast, prescription drugs can be sold only to consumers having a legal prescription. OTC drugs are carefully chosen by regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Strategic alliances among vendors that lead to market consolidation are expected to have a positive impact on market growth during the forecast period. Collaborations among the leading vendors help them to obtain an edge over smaller companies. According to the report, the increased patient population has a positive impact on market growth. The growing incidence of gastrointestinal disorders and a rise in the geriatric population has led to an increase in the overall patient population. Patients undergo self-diagnosis and self-medication leading to increased consumption of OTC drugs. Further, the report states that increased expenditure on advertisements of the drugs hinders the growth of the market. To calculate the market size, the report considers revenue from the sales of various OTC drugs available in the market for the management of gastrointestinal disorders such as: - GERD/Heartburn - Constipation - Diarrhea - Nausea due to motion sickness - Flatulence Key vendors - Bayer - GlaxoSmithKline - Johnson & Johnson - Perrigo - Pfizer - Procter & Gamble Other prominent vendors - Abbott - Boehringer Ingelheim - C.B. Fleet - Nestle - Omega - Purdue Pharma - Reckitt Benckiser - Sanofi - Teva Pharmaceutical For more information visit http://www.researchandmarkets.com/research/6bnnqx/global
JNJ: 103.42 (+1.12), PRGO: 198.37 (+3.87), PG: 80.74 (-0.31), GSK: 44.66 (-0.11)
New Report Highlights Lack of Chemical Screening Criteria in Cleaning Industry
GlobeNewswire - Tue Apr 28, 10:37AM CDT
A new report released by national women's health non-profit, Women's Voices for the Earth (WVE), finds that the cleaning product industry is falling short in meeting consumer demands for safer products.
The Weekender
Aviate - at Seeking Alpha - Sun Apr 26, 12:25AM CDT
Reading the tea leaves Earnings season brings with it a deluge of corporate numbers and whilst it can be easy to get caught up in the micro, we have spent much time this week looking through the numbers and focusing on what corporates are telling...
VGK: 58.07 (-0.35), PCAR: 65.77 (-0.68), TI: 12.31 (-0.22), ILMN: 200.76 (+1.69), SPY: 213.10 (+0.66), SAP: 75.63 (-1.20), DIA: 182.68 (+0.20), HBI: 31.83 (+0.52), RIO: 45.64 (-0.49), ALU: 3.77 (+0.01), ALV: 126.18 (+1.39), MAN: 87.08 (+0.89), WPPGY: 122.67 (+0.03), EU: 20.54 (-0.08), VOD: 36.51 (-0.53), TUP: 67.55 (+0.49), ABB: 22.15 (-0.06), NVO: 56.92 (+0.17), QQQ: 110.06 (+0.48), ARMH: 52.19 (+0.39), CRH: 28.57 (-0.19)
Solid Q1 for Reckitt Benckiser
Seeking Alpha - at Seeking Alpha - Fri Apr 24, 8:07AM CDT
European Stocks Take Positive View of Greece Debt Talks; HSBC Rises
at The Street - Fri Apr 24, 5:13AM CDT
European stocks are rising as European ministers meet with Greece over bailout funds and as HSBC threatens to leave the U.K.
GE: 27.31 (+0.04), HSBC: 48.45 (-0.36)
